A Review of Vaccine Research and Development: Meningococcal Disease
This article, published in Vaccine, reviews the current status of research and development of vaccines against meningococcal disease due to Neisseria meningitidis. The authors discuss the successes of Group C meningitis vaccines in several European countries and a new Group A meningitis vaccine candidate in development that could potentially help eliminate widespread outbreaks in Africa's meningitis belt. The article also emphasizes the importance of developing a meningococcal vaccine against Group B meningitis to achieve effective prevention on a global scale. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Girard MP, Preziosi MP, Aguado MT, Kieny MP
Visit web page (English)
(Located at www.ncbi.nlm.nih.gov)
Citation: Girard MP, Preziosi MP, Aguado MT, Kieny MP. A Review of Vaccine Research and Development: Meningococcal Disease. Vaccine. 2006;24(22):4692-4700.